Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-10-07
1996-04-30
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514170, 514171, 514178, A61K 3156
Patent
active
055125573
ABSTRACT:
Use of 17.beta.-oestradiol in the treatment of coronary heart disease.
REFERENCES:
Godsland, I. F., et al., "Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questions," American Heart Journal: vol. 114, No. 6, pp. 1467-1503 (Dec. 1987).
Rosano Giuseppe M. C., et al., "Beneficial effect of estradiol 17-bet on exercise-induced myocardial ischaemia in woman with coronary arter disease. A double blind randomized placebo controlled study" J. Am Coll. Cardiol., vol. 21, No. 2, Suppl. A). pp. 64A, 1993. 42nd Ann. Scientific Session of the Am. Coll. of Cardiology (Mar. 14-18 1993).
Rosano, Giuseppe M. C., et al., "Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in woman with coronary artery disease," The Lancet, vol. 342, pp. 133-136 (Jul. 17, 1993).
Bain, Christopher, et al., "Use of Postmenopausal Hormones and Risk of Myocardial Infarction," Circulation, vol. 64, No. 1, pp. 42-(1981).
Barr, David P. et al. "Influences of Estrogen on Lipoproteins in Atherosclerosis" Trans. Assoc. Am. Physicians, 1952, 65:102.
Colditz, Graham A. et al., "Menopause and the Risk of Coronary Heart Disease in Women," The New England Journal of Medicine, vol. 316, No. 18, pp. 1105-1110 (1987).
Gordon, Tavia, et al., "Menopause and Coronary Heart Disease," Annals of Internal Medicine, vol. 89, No. 2, pp. 167-161 (1978).
Hammond, Charles B., "Effects of long-term estrogen replacement therapy," Am J. Obstet Gynecology, vol. 133, No. 5, pp. 525-536 (1979).
Petitti, Diana B., et al. "Risk of Vascular Disease in Women," JAMA, vol. 242, No. 11, pp. 1150-1154 (1979).
Pfeffer, R. I., et al., "Coronary Risk and Estrogen Use in Postmenopausal Woman," American Journal of Epidemiology, vol. 107, No. 6, pp. 479-487 (1978).
Rosenberg, Lynn, et al. "Myocardial Infarction and Estrogen Therapy in Post-Menopausal Women," The New England Journal of Medicine, vol. 294, No. 23, pp. 1256-1259 (1976).
Rosenberg, Lynn, et al., "Noncontraceptive Estrogens and Myocardial Infarction in Young Women," JAMA, vol. 244, No. 4, pp. 339-342 (1980).
Ross, Ronald K., et al. "Menopausal Oestrogen Therapy and Protection from Death from Ischaemic Heart Disease," The Lancet, Apr. 18, 1981, pp. 858-860.
Stampfer, Meir J. et al. "A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart Disease," The New England Journal of Medicine, vol. 313, No. 17, pp. 1044-1049 (1985).
Szklo, Moyses, et al. "Estrogen Use and Myocardial Infarction Risk: A Case-Control Study," Preventive Medicine, vol. 13, pp. 510-516 (1984).
Wilson, W. F., et al. "Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Woman Over 50," The New England Journal of Medicine, vol. 313, No. 17, pp. 1038-1043 (1985).
American Heart Association, "Supplement to Circulation vol. 86, No. 4 Oct. 1992, p. I-537, abst 2137, Abstracts from the 65th Scientific Session," (Nov. 16-19, 1992).
Bush, Trudy L., et al., "Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study," Circulation, vol. 75, pp. 1102-1109 (1987).
Colditz, Graham A., et al., "Menopause and the Risk of Coronary Heart Disease in Women," The New England Journal of Medicine, vol. 316, No. 8, pp. 1105-1110 (1987).
Earl R. Plunkett, et al; Amer. J. Obstet Gynecol. Jan., 1992, pp. 117-121.
Criares Theodore J.
Myers Louis
National Heart and Lung Institute
LandOfFree
Coronary heart disease treated with 17.beta.oestradiol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Coronary heart disease treated with 17.beta.oestradiol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coronary heart disease treated with 17.beta.oestradiol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-628785